Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein

Cell Biochemistry and Biophysics

Volumn 44, Issue 3, 2006, Pages 313-324

  Bonaldo, Myrna C ^a   Garratt, Richard C ^b   Freire, Marcos S ^c   Galler, Ricardo ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Attenuation; E protein structure; Foreign epitope expression; Yellow fever 17D virus

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; GLYCOPROTEIN E, FLAVIVIRUS; LIVE VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS RNA; YELLOW FEVER VACCINE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; GENETICS; IMMUNOLOGY; MOLECULAR CLONING; MOUSE; PROTEIN CONFORMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TICK BORNE ENCEPHALITIS FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

ANIMALS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENCEPHALITIS VIRUSES, TICK-BORNE; EPITOPES; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

ACARI; FLAVIVIRUS; YELLOW FEVER VIRUS; YELLOW FEVER VIRUS (STRAIN 17D); IXODIDA;

EID: 33646893262     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:44:3:313     Document Type: Conference Paper

References (56)

1. Rice, C. M., Lenches E. M., Eddy S. R., Shin S. J., Sheets R. L., and Strauss, J. H. (1985) Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229, 726-733.
2. Monath, T. P. and Barrett, A. D. (2003) Pathogenesis and pathophysiology of yellow fever. Adv. Virus Res. 60, 343-395.
3. 2a. Rice, C.M., Grakoui, A., Galler, R., and Chambers, T. J., (1984) Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1, 285-296.
4. Lai, C. J. and Monath, T. P. (2003) Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv. Virus Res. 61, 469-509.
5. Pugachev, K. V., Guirakhoo, F., Trent D. W., and Monath, T. P. (2003) Traditional and novel approaches to flavivirus vaccines. Int. J. Parasitol. 33, 567-582.
6. Rose, C. S. and Evans, D. J. (1991) Poliovirus antigen chimeras. Trends Biotechnol. 9, 415-421.
7. Murray, M. G., Kuhn, R. J., Arita, M., Kawamura, N., Nomoto, A., and Wimmer, E. (1988) Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc. Natl. Acad. Sci. USA 85, 3203-3207.
8. Lemon, S. M., Barclay, W., Ferguson, M., et al. (1992) Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV. Virology 188, 285-295.
9. London, S. D., Schmaljohn, A. L., Dalrymple, J. M., and Rice, C. M. (1992) Infectious enveloped RNA virus antigenic chimeras. Proc. Natl. Acad. Sci. USA 89, 207-211.
10. Sedlik, C., Sarraseca, J., Rueda, P., Leclerc, C., and Casal, I. (1995) Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles. J. Gen. Virol. 76, 2361-2368.
11. Bendahmane, M., Koo, M., Karrer, E., and Beachy R. N. (1999) Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions. J. Mol. Biol. 290, 9-20.
12. Rueda, P., Hurtado, A., del Barrio, M., et al. (1999) Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles. Virology 263, 89-99.
13. Ulrich, R., Koletzki, D., Lachmann, S. (1999) New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. J. Biotechnol. 73, 141-153.
14. Gedvilaite, A., Frommel, C., Sasnauskas, K., et al. (2000) Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 273, 21-35.
15. Heal, K. G., McConkey, G. A., Hormaeche, C. E., Hollingdale, M. R., Khan, C. M., and Taylor-Robinson, A. W. (2000) Expression of TetC fusion proteins from Salmonella in a gaseous environment that models conditions found in mammalian tissues. Biotechniques 28, 228-230, 232.
16. de Vries, A. A., Glaser, A. L., Raamsman, M. J., et al. (2000) Genetic manipulation of equine arteritis virus using full-length cDNA clones: separation of overlapping genes and expression of a foreign epitope. Virology 270, 84-97.
17. Fayolle, C., Osickova, A., Osicka, R., et al. (2001) Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. J. Virol. 75, 7330-7338.
18. Avall-Jaaskelainen, S., Kyla-Nikkila, K., Kahala, M., Miikkulainen-Lahti, T., and Palva, A. (2002) Surface display of foreign epitopes on the Lactobacillus brevis S-layer. Appl. Environ. Microbiol. 68, 5943-5951.
19. Birkett, A., Lyons, K., Schmidt, A., et al. (2002) A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect. Immun. 70, 6860-6870.
20. Halim, S. S., Ostrowski, S. E., Lee, W. T., and Ramsingh, A. I. (2000) Immunogenicity of a foreign peptide expressed within a capsid protein of an attenuated coxsackievirus. Vaccine 19, 958-965.
21. Mebatsion, T., Koolen, M. J., de Vaan, L. T., et al. (2002) Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J. Virol. 76, 10,138-10,146.
22. Moradpour, D., Evans, M. J., Gosert, R., et al. (2004) Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78, 7400-7409.
23. Rey F. A., Heinz, F. X., Mandl, C., Kunz, C., and Harrison, S. C. (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375, 291-298.
24. Heinz, F. X. and Allison, S. L. (2001) The machinery for flavivirus fusion with host cell membranes. Curr. Opin. Microbiol. 4, 450-455.
25. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 100, 6986-6991.
26. Kuhn, R. J., Zhang, W., Rossmann, M. G., et al. (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725.
27. Allison, S. L., Schalich, J., Stiasny K., Mandl, C. W., and Heinz, F. X. (2001) Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75, 4268-4275.
28. Crill, W. D. and Roehrig, J. T. (2001) Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769-7773.
29. Beasley, D. W. and Barrett, A. D. (2002) Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 76, 13,097-14,100.
30. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2005) Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 79, 1223-1231.
31. Stiasny K., Allison, S. L., Marchler-Bauer, A., Kunz, C., and Heinz, F. X. (1996) Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 70, 8142-8147.
32. Bressanelli, S., Stiasny, K., Allison, S. L., et al. (2004) Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23, 728-738.
33. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319.
34. Zhang, Y., Zhang, W., Ogata, S., et al. (2004) Conformational changes of the flavivirus E glycoprotein. Structure 12, 1607-1618.
35. Barton, G. J. and Sternberg, M. J. (1987) A strategy for the rapid multiple alignment of protein sequences. Confidence levels from tertiary structure comparisons. J. Mol. Biol. 198, 327-337.
36. Sali, A. and Blundell, T. L. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815.
37. Braun, W. and Go, N. (1985) Calculation of protein conformations by proton-proton distance constraints. A new efficient algorithm. J. Mol. Biol. 186, 611-626.
38. Nicholls, A., Sharp, K. A., and Honig, B. (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
39. Bonaldo, M. C., Garratt, R. C., Caufour, P. S., et al. (2002) Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J. Mol. Biol. 315, 873-885.
40. Caufour, P. S., Motta, M. C., Yamamura, A. M., et al. (2001) Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. Virus Res. 279, 1-14.
41. Laskowski, R. A., Macarthur, M. W., Moss, D. S., and Thornton, J. M. (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystogr. 26, 283-291.
42. Bowie, J. U., Luthy R., and Eisenberg, D. (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253, 164-170.
43. Luthy, R., Bowie, J. U., and Eisenberg, D. (1992) Assessment of protein models with three-dimensional profiles. Nature 356, 83-85.
44. Eisenberg, D., Luthy, R., and Bowie, J. U. (1997) VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 277, 396-404.
45. Vriend, G. (1990) WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8, 52-56, 29.
46. Vriend, G. and Sander, C. (1993) Quality-control of proteins models-directional atomic contact analysis. J. Appl. Crystallogr. 26, 47-60.
47. Rothman, A. L., Kurane, I., and Ennis, F. A. (1996) Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus. J. Virol. 70, 6540-6546.
48. Takada, K., Masaki, H., Konishi, E., Takahashi, M., and Kurane, I. (2000) Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes. Arch. Virol. 145, 523-534.
49. Co, M. D., Terajima, M., Cruz, J., Ennis, F. A., and Rothman, A. L. (2002) Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on non-structural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293, 151-163.
50. van der Most, R. G., Harrington, L. E., Giuggio, V., Mahar, P. L., and Ahmed, R. (2002) Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology 296, 117-124.
51. Wallace, A. C., Laskowski, R. A., and Thornton, J. M. (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134.
52. Chambers, T. J., Hahn, C. S., Galler, R., and Rice, C. M. (1990) Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44, 649-688.
53. Volk, D. E., Beasley D. W., Kallick, D. A., Holbrook, M. R., Barrett A. D., and Gorenstein, D. G. (2004) Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J. Biol. Chem. 279, 38,755-38,761.
54. Nickells, M. and Chambers, T. J. (2003) Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice. J. Virol. 77, 12,232-12,242.
55. Leszczynski, J. F. and Rose, G. D. (1986) Loops in globular proteins: a novel category of secondary structure. Science 234, 849-855.
56. Rothman, A. L. (2004) Dengue: defining protective versus pathologic immunity. J. Clin. Investig. 113, 946-951.